Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1997-1-14
pubmed:abstractText
Corticosteroids are effective in acute Crohn's disease (CD). The present study assessed the effectiveness and safety of oral pH-modified release budesonide (BUD) in patients with active CD in comparison with 6-methylprednisolone (MPred).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0954-691X
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
905-9
pubmed:dateRevised
2009-10-16
pubmed:meshHeading
pubmed-meshheading:8889459-Administration, Oral, pubmed-meshheading:8889459-Adult, pubmed-meshheading:8889459-Anti-Inflammatory Agents, pubmed-meshheading:8889459-Budesonide, pubmed-meshheading:8889459-Crohn Disease, pubmed-meshheading:8889459-Delayed-Action Preparations, pubmed-meshheading:8889459-Double-Blind Method, pubmed-meshheading:8889459-Drug Administration Schedule, pubmed-meshheading:8889459-Female, pubmed-meshheading:8889459-Glucocorticoids, pubmed-meshheading:8889459-Humans, pubmed-meshheading:8889459-Hydrogen-Ion Concentration, pubmed-meshheading:8889459-Male, pubmed-meshheading:8889459-Methylprednisolone, pubmed-meshheading:8889459-Middle Aged, pubmed-meshheading:8889459-Pregnenediones, pubmed-meshheading:8889459-Prospective Studies, pubmed-meshheading:8889459-Remission Induction
pubmed:year
1996
pubmed:articleTitle
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
pubmed:affiliation
Department of Internal Medicine, Universities of Regensburg.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study